SCHEMBL4856503

SCHEMBL4856503

COc1ccc(/C=C/C(=O)c2cc(-c3ccccc3OC)ccc2OCCN(C)C)c(Cl)c1

nearest known ligand 0.49

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ABCG2 Q9UNQ0 2/20 0.49
KDM4E B2RXH2 2/20 0.45
MAPT P10636 4/20 0.43
NPC1 O15118 2/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
HTR7 P34969 1/20 0.43
SMN1; SMN2 Q16637 3/20 0.43
LMNA P02545 1/20 0.43
GAA P10253 1/20 0.43
ATM Q13315 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
TNFRSF1A P19438 1/20 0.42
ALDH1A1 P00352 2/20 0.42
SLC6A9 P48067 1/20 0.42
PDE4A P27815 1/20 0.41
PDE4B Q07343 1/20 0.41
PDE4C Q08493 1/20 0.41
PDE4D Q08499 1/20 0.41
RAB9A P51151 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4854786 1.00 ABCG2 (0.49) ABCG2KDM4EMAPTNPC1L3MBTL1
SCHEMBL4856317 0.92 ABCG2 (0.46) ABCG2KDM4EMAPTNPC1L3MBTL1
SCHEMBL4848031 0.92 ABCG2 (0.46) ABCG2KDM4EMAPTNPC1L3MBTL1
SCHEMBL4854790 0.90 ABCG2 (0.50) ABCG2KDM4EMAPTNPC1L3MBTL1
SCHEMBL4852991 0.90 ABCG2 (0.49) ABCG2KDM4EMAPTNPC1SMN1; SMN2
SCHEMBL4847513 0.90 ABCG2 (0.49) ABCG2KDM4EMAPTNPC1SMN1; SMN2
SCHEMBL4851264 0.90 MAPT (0.45) KDM4EMAPTHTR7SMN1; SMN2LMNA
SCHEMBL4848064 0.90 MAPT (0.45) KDM4EMAPTHTR7SMN1; SMN2LMNA
SCHEMBL4846085 0.87 TUBB4A (0.53) ABCG2MAPTNPC1HTR7GAA
SCHEMBL4852250 0.87 TUBB4A (0.53) ABCG2MAPTNPC1HTR7GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7423181-B2 in particular against bacterial and parasitic infections, fungi, and helminths; improved metabolic and physiochemical properties, bioavailability, solubility; 3-[4-(2-Dimethylamino-ethoxy)-2'-trifluoromethyl-biphenyl-3-yl]-1-(2-dimethylaminomethyl-phenyl)-propenone LICA PHARMACEUTICALS A/S (DK) 2008-09-09 US disclosed
US-20050227990-A1 Aminoalkoxy-functional chalcones LICA PHARMACEUTICALS A/S (DK) 2005-10-13 US disclosed